Announcements Trials
Browse Landscape

Phase

Phase NA 66Phase 3 7Phase 2 7Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 182Gastrointestinal 23Genitourinary 20Thoracic 19Gynecologic 13Dermatologic 10Sarcoma 9Head & Neck 9CNS 8Other 2Lymphoid 2Endocrine 2

Conditions

Obesity 11Polycystic Ovary Syndrome 4Overweight 2Endometrial Neoplasms 2Diabetes Mellitus 2Breast Neoplasms 2Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Periodontitis 1Neuritis 1Mucositis 1Metabolic Syndrome 1Insulin Resistance 1Hyperlipidemias 1Hematopoietic and Lymphoid System Neoplasm 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Cancer-related Fatigue 1Bone Diseases 1

Interventions

Phenylephrine 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Other × Clear all
NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Applied Biology, Inc.

Phase EARLY_PHASE1 Completed
3 enrolled 6 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

NCT01793948 2018-03-30

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

Indiana University

Phase EARLY_PHASE1 Completed
24 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡